Osteocalcin (BGLAP) promoter (BGLAP promoter)

The Osteocalcin (BGLAP) promoter is a bone-specific DNA regulatory element that controls the expression of osteocalcin, a key protein in bone mineralization (UniProt P02818). In the field of gene therapy and oncolytic virology, this promoter is utilized to drive a "transcriptional program" that restricts the expression of therapeutic genes to host cells with active bone-forming machinery, such as osteoblasts and bone-metastatic cancer cells (Koeneman et al., 2000). This selectivity is mediated by the binding of the transcription factor RUNX2 to specific response elements within the promoter sequence. Therapeutic strategies, such as the use of the Ad-OC-TK adenoviral vector, leverage this program to deliver suicide genes like Herpes Simplex Virus Thymidine Kinase (HSV-TK) specifically to bone tumors, thereby inducing targeted cell death upon administration of ganciclovir (Matsubara et al., 2001). This approach is particularly relevant for treating osteosarcoma and bone metastases from prostate or breast cancer, where the osteocalcin promoter is aberrantly or highly active. However, challenges remain regarding the efficiency of viral delivery to bone tissue and the potential for immune-mediated clearance of the vector (Gardner et al., 2000).

Other names

hOC promoterHuman osteocalcin promoterBone gamma-carboxyglutamate protein promoterBGLAP regulatory element

Selective transcriptional activation of therapeutic genes or viral replication in host cells expressing bone-specific transcription factors like RUNX2.